Format

Send to

Choose Destination
Drug Discov Ther. 2013 Jun;7(3):109-15.

Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments.

Author information

1
Departments of Pharmaceutical Sciences, South Dakota State University, Brookings, SD, USA.

Abstract

α-Santalol is active component of sandalwood oil and has been shown to have chemopreventive effects against chemically and UVB-induced skin cancer development in mice. α-Santalol is also shown to have skin permeation enhancing effects. Honokiol and magnolol isolated from Magnolia officinalis bark extract have also been shown to have chemopreventive effects against chemically and UVB-induced skin cancer in mice. This study was conducted to investigate the combination effects of α-santalol, honokiol and magnolol to study any additive/synergistic effects to lower the doses required for chemoprevention. Pretreatment of combinations of α-santalol with honokiol and magnolol significantly decreased tumor multiplicity upto 75% than control, α-santalol, honokiol and magnolol alone in SKH-1 mice. Combination of α-santalol with honokiol and magnolol also decreased cell viability, proliferation, and enhanced apotosis in comparison to α-santalol, honokiol and magnolol alone in Human epidrmoid carcinoma A431 cells. Overall, the results of present study indicated combinations of α-santalol with honokiol and magnolol could provide chemoprevention of skin cancer at lower doses than given alone.

PMID:
23917859
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for IRCA-BSSA Group
Loading ...
Support Center